Archive | April, 2011

The Hidden Costs Of Prescription Drug Development That Nobody Likes To Talk About!

Depending upon the source, the cost of bringing a new prescription drug to market these days ranges from roughly $1.2 to 1.5 billion. While there is no question that clinical studies represent the most costly aspect of getting new drugs approved, the hidden costs—mainly promotion and marketing—are what actually inflate the costs of new drug development. Not […]

Continue Reading

A lot of Spectroscopy and a Little Maths

Uranium hard drive – A new uranium-containing compound maintains its magnetic behaviour at low temperatures. The discovery could take us a step closer to magnetic memory devices with capacities thousands of times denser than current high-end hard drives. spectroscopynow.com/coi/cda/detail.cda?id=25360&type=Feature&chId=3&page=1″>Clouds from both sides – Atmospheric and climate models may have overlooked the fact that exactly how […]

Continue Reading

BIO Humanitarian Award Deadline for Nominations is April 15

Today, the Biotechnology Industry Organization (BIO) announced a distinguished panel of judges who will evaluate nominations for the third annual Biotech Humanitarian Award and select the 2011 Honoree.  BIO created the Award to recognize an everyday hero who has helped to heal, fuel and feed the planet through their work in or support of biotechnology.  […]

Continue Reading

Chemical elements in limited supply

During the second half of 2010 a term usually reserved to specialized audiences started to spread in mainstream media: the rare-earth elements. Although they are not so scarce as their name would suggest, increasing concerns about their availability in the near future were expressed, and a recent issue of Nature Materials featured several articles dedicated […]

Continue Reading